Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov 21;9(11):1269.
doi: 10.3390/nu9111269.

Impact of High-Dose Multi-Strain Probiotic Supplementation on Neurocognitive Performance and Central Nervous System Immune Activation of HIV-1 Infected Individuals

Giancarlo Ceccarelli  1 , Jason M Brenchley  2 , Eugenio Nelson Cavallari  3 , Giuseppe Corano Scheri  4 , Mariangela Fratino  5 , Claudia Pinacchio  6 , Ivan Schietroma  7 , Saeid Najafi Fard  8 , Carolina Scagnolari  9 , Ivano Mezzaroma  10 , Vincenzo Vullo  11 , Gabriella d'Ettorre  12
Affiliations

Impact of High-Dose Multi-Strain Probiotic Supplementation on Neurocognitive Performance and Central Nervous System Immune Activation of HIV-1 Infected Individuals

Giancarlo Ceccarelli et al. Nutrients. .

Abstract

Background: Gut microbiota has metabolic activity which influences mucosal homeostasis, local and systemic immune responses, and other anatomical systems (i.e., brain). The effects of dysbiosis are still poorly studied in Human Immunodeficiency Virus-1 (HIV-1) positive subjects and insufficient data are available on the impairment of the gut-brain axis, despite neurocognitive disorders being commonly diagnosed in these patients. This study evaluated the impact of a probiotic supplementation strategy on intrathecal immune activation and cognitive performance in combined antiretroviral therapy (cART) treated HIV-1 infected subjects.

Methods: Thirty-five HIV-1 infected individuals were included in this study. At baseline (T0) a battery of tests was administered, to evaluate neurocognitive function and a lumbar puncture was performed to determine neopterin concentration in cerebrospinal fluid (CSF), as a marker of Central Nervous System (CNS) immune activation. Subsequently, a subgroup of participants underwent a 6-month course of multi-strain probiotics supplementation; this intervention group was evaluated, after probiotic treatment, with a second lumbar puncture and with repeated neurocognitive tests.

Results: At T0, all participants showed impaired results in at least one neurocognitive test and elevated neopterin concentrations in CSF. After supplementation with probiotics (T6), the interventional group presented a significant decrease in neopterin concentration and a significant improvement in several neurocognitive tests. In contrast, no significant modifications were observed in the neurocognitive performance of controls between T0 and T6. The CNS Penetration Effectiveness Score of antiretroviral therapy did not show an influence from any of the investigated variables.

Conclusions: Multi-strain probiotic supplementation seems to exert a positive effect on neuroinflammation and neurocognitive impairment in HIV-1 infected subjects, but large trials are needed to support the concept that modulation of the gut microbiota can provide specific neurological benefits in these patients.

Keywords: HIV; asymptomatic neurocognitive impairment; central nervous system; dysbiosis; gut-brain axis; immune activation; multi-strain; neopterin; probiotic; supplementation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest and no founding sponsors.

Figures

Figure 1
Figure 1
The design of the study. (Abbreviations. HIV: Human Immunodeficiency Virus).
See this image and copyright information in PMC

References

    1. Heaton R.K., Franklin D.R., Ellis R.J., McCutchan J.A., Letendre S.L., LeBlanc S., Corkran S.H., Duarte N.A., Clifford D.B., Woods S.P., et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors. J. Neurovirol. 2011;17:3–16. doi: 10.1007/s13365-010-0006-1. - DOI - PMC - PubMed
    1. Dinan T.G., Stilling R.M., Stanton C., Cryan J.F. Collective unconscious: How gut microbes shape human behavior. J. Psychiatr. Res. 2015;63:1–9. doi: 10.1016/j.jpsychires.2015.02.021. - DOI - PubMed
    1. Akbari E., Asemi Z., Daneshvar Kakhaki R., Bahmani F., Kouchaki E., Tamtaji O.R., Hamidi G.A., Salami M. Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer’s Disease: A Randomized, Double-Blind and Controlled Trial. Front. Aging Neurosci. 2016;8:256. doi: 10.3389/fnagi.2016.00256. - DOI - PMC - PubMed
    1. Huang R., Wang K., Hu J. Effect of Probiotics on Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2016;8:483. doi: 10.3390/nu8080483. - DOI - PMC - PubMed
    1. Zilberman-Schapira G., Zmora N., Itav S., Bashiardes S., Elinav H., Elinav E. The gut microbiome in human immunodeficiency virus infection. BMC Med. 2016;14:83. doi: 10.1186/s12916-016-0625-3. - DOI - PMC - PubMed

MeSH terms